Robert Hong

Robert Hong

Auto-generated profile, based on publicly available information

Robert Hong

Michigan Ear Institute, Farmington Hills, Michigan

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2004 in Circulation
Verified
Journal Article
Closed access
CPCarlo Pappone
Carlo Pappone
HOHakan Oral
Hakan Oral
VSVincenzo Santinelli
Vincenzo Santinelli
GVGabriele Vicedomini
Gabriele Vicedomini
CLChristopher C. Lang
Christopher C. Lang
FMFred Morady
Fred Morady
Background— Radiofrequency ablation for atrial fibrillation is becoming widely practiced. Methods and Results— Two patients undergoing circumferential pulmonary vein ablation for atrial fibrillation in different centers developed symptoms compatible with endocarditis 3 to 5 days after the procedure. Their clinical condition deteriorated rapidly, and both suffered multiple gaseous and/or septic embolic events causing cerebral and myocardial damage. One patient survived after emergency cardiac and esophageal surgery; the other died of extensive systemic embolization. An atrio-esophageal fistula was identified in both patients. Conclusions— Atrio-esophageal fistulas can occur after catheter ablation in the posterior wall of the left atrium. This diagnosis should be excluded in any patient with symptoms or signs of endocarditis after left atrial ablation, and expeditious cardiac surgery is critical if the diagnosis is confirmed. Lower power and temperature settings for applications of radiofrequency energy along the posterior left atrial wall may prevent further cases of fistula formation.

27 August 2013 in Clinical Cardiology
Verified
Journal Article
Open access
PDF file
SWSekon Won
Sekon Won
RHRobert A. Hong
Robert A. Hong
RSRalph V. Shohet
Ralph V. Shohet
TSTodd B. Seto
Todd B. Seto
NPNisha I. Parikh
Nisha I. Parikh
Methamphetamine and related compounds are now the second most commonly used illicit substance worldwide, after cannabis. Reports of methamphetamine‐associated cardiomyopathy (MAC) are increasing, butMAChas not been well reviewed. This analysis ofMACwill provide an overview of the pharmacology of methamphetamine, historical perspective and epidemiology, a review of case and clinical studies, and a summary of the proposed mechanisms forMAC. Clinically, many questions remain, including the appropriate therapeutic interventions forMAC, the incidence and prevalence of cardiac pathology in methamphetamine users, risk factors for developingMAC, and prognosis of these patients. In conclusion, recognition of the significance ofMACamong physicians and other medical caregivers is important given the growing use of methamphetamine and related stimulants worldwide.

1 April 2006 in JACC
Verified
Journal Article
Closed access
Timothy HenryTimothy Henry
Timothy Henry
JAJames M. Atkins
James M. Atkins
MCMichael S. Cunningham
Michael S. Cunningham
GFGary S. Francis
Gary S. Francis
WGWilliam J. Groh
William J. Groh
WWW. Douglas Weaver
W. Douglas Weaver

1 February 1988 in American Heart Journal
Verified
Journal Article
Closed access
DKDaniel L. Kulick
Daniel L. Kulick
RHRobert Hong
Robert Hong
ERElisabeth Ryzen
Elisabeth Ryzen
RRRobert K. Rude
Robert K. Rude
JRJ. Nathan Rubin
J. Nathan Rubin
ABAnil K. Bhandari
Anil K. Bhandari

23 December 2010 in Clinical Cardiology
Verified
Journal Article
Closed access
PDF file
RHRobert A. Hong
Robert A. Hong
TITakeshi Iimura
Takeshi Iimura
KSKenneth N. Sumida
Kenneth N. Sumida
RERobert M. Eager
Robert M. Eager

1 June 1986 in American Heart Journal
Verified
Journal Article
Open access
RHRobert A. Hong
Robert A. Hong
JLJonathan D. Licht
Jonathan D. Licht
JWJeanne Y. Wei
Jeanne Y. Wei
GHGary V. Heller
Gary V. Heller
ABAlvin S. Blaustein
Alvin S. Blaustein
RPRichard C. Pasternak
Richard C. Pasternak
To test the hypothesis that patients with normal serum levels of creatine kinase (CK) but elevated percentages of MB isoenzyme fractions in suspected myocardial infarction may have sustained clinically significant events, we studied the hospital course of 347 consecutive patients admitted with suspected myocardial infarction. Two hundred twenty-three patients had normal CK levels (182 +/- 44 IU) and normal MB percentages (normal group), 68 had elevated levels of both CK (1395 +/- 178 IU) and MB percentage (10.5 +/- 0.6) (macroinfarction group), and 40 had normal CK levels (96 +/- 7 IU) but elevated MB percentages (9.6 +/- 0.5) with typical enzyme curves (microinfarction group). Compared to the normal group, microinfarction patients were older, had more congestive heart failure, required more intensive monitoring and therapy during longer stays, and sustained a higher in-hospital mortality rate. Thus, these microinfarction patients are at increased risk and therefore warrant aggressive treatment and further evaluation.